Cardiac Imaging: Page 217

UltraSPECT reaches U.S. milestone

By AuntMinnie.com staff writers

Nuclear medicine firm UltraSPECT of Merrick, NY, has recorded its 100th installation in the U.S.

July 31, 2007

Boston Scientific begins Taxus Element stent trial

By AuntMinnie.com staff writers

Interventional device developer Boston Scientific of Natick, MA, has begun trials for its first third-generation paclitaxel-eluting coronary stent, Taxus Element. The trial will include 1,500 patients at 100 U.S. and international centers.

July 19, 2007

Abbott begins stent trial for cardiovascular disease

By AuntMinnie.com staff writers

Abbott Laboratories of Abbott Park, IL, has enrolled the first patient in a new clinical trial of the company's Xience V everolimus-eluting stent.

July 19, 2007

Cancer risk and cardiac CTA; DICOM for your CR/DR QC station

By Brian Casey

July 16, 2007

JAMA study: Coronary CTA poses substantial cancer risk in select patients

By Cheryl Hall Harris, R.N.

Sixty-four slice coronary CT angiography (CTA) forges ahead as the go-to imaging modality in coronary artery disease, but the diagnostic test carries a significant risk for radiation-induced cancer, especially in women and younger patients, according to a study published today in the Journal of the American Medical Association.

July 16, 2007

Medrad nets Premier extension

By AuntMinnie.com staff writers

Contrast injector firm Medrad said that it has received a two-year contract extension from group purchasing organization Premier to provide its vascular injection systems and related disposables used in CT, MR, and cardiovascular imaging.

July 16, 2007